Prothena Corporation plc ( PRTA) - Key Metrics
PRTA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.02 | -$0.36 | -$0.48 | -$0.49 |
| 2026Q1 | $0.95 | $0.61 | $0.54 | $0.54 |
| 2025Q4 | $0 | -$0.40 | -$0.43 | -$0.43 |
| 2025Q3 | $0.04 | -$0.68 | -$0.75 | -$0.75 |
| 2025Q2 | $0.08 | -$2.34 | -$0.86 | -$0.86 |
PRTA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.80 |
| 2026Q1 | 0% | 3.98 |
| 2025Q4 | 0% | -5.97 |
| 2025Q3 | 0% | -3.59 |
| 2025Q2 | 0% | -0.65 |
PRTA
Price: $8.35
52 week price:
Earnings Per Share: -0.82 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Ireland
Volume: 314000
Ebitda: -47.3 millionMarket Capitalization: 424.0 million